EUVIMEDOpdag EUVIMED
Multizentrische Studie

Afterload mismatch after transcatheter edge‐to‐edge repair in functional mitral regurgitation: A propensity‐score matched analysis

Filippo Angelini iD, Stefano Pidello, Simone Frea, Pier Paolo Bocchino, Alessandro Mandurino Mirizzi iD, Anna Giulia Pavon, Carolina Montonati, Francesco Giannini, Davide Giovannini, Antonio Mangieri, Bernhard Reimers, Paolo Boretto and 11 more

European Journal of Clinical Investigation · 2025-08 · 55 (8)

DOI: 10.1111/eci.70040 ↗

At a glance

Multizentrische Studie in European Journal of Clinical Investigation, published online on 2025-03-27. Written by Filippo Angelini and 22 co-authors. Institution: Division of Cardiology, Cardiovascular and Thoracic Department, 'Città Della Salute e Della Scienza' Hospital, Torino, Italy. Major MEDLINE topics: Mitral Valve Insufficiency, Ventricular Dysfunction, Left. Cited 4 times so far (Crossref); 24 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Transcatheter edge‐to‐edge repair (TEER) for severe functional mitral regurgitation (FMR) in patients with reduced left ventricular ejection fraction (LVEF) may lead to an acute increase in left ventricular afterload, termed afterload mismatch (AM). This study aimed to redefine AM clinically, analyse its determinants, and assess its prognostic impact post‐TEER in FMR patients.

Methods

A multicenter case–control study was conducted, involving FMR patients with LVEF ≤35% undergoing TEER. AM post‐TEER was defined as the acute (within 24 h) need for escalation of inotropic or mechanical circulatory support. Sixty‐eight AM cases were compared with 68 propensity‐matched patients. Primary endpoints included in‐hospital mortality post‐TEER and 2‐year all‐cause mortality.

Results

Median age was 68 years, 76% male. Procedural success was achieved in 92% of patients. Proportionate MR was associated with a higher risk of AM (adj‐HR 1.6, 95% CI 1.01–2.6, p = .04). Conversely, pretreatment with levosimendan (adj‐HR .29, 95% CI .12–.70, p < .01) and higher furosemide dose (adj‐HR per furosemide 10 mg increase .86, 95% CI .76–.98, p = .03) were protective. In‐hospital mortality was higher in the AM cohort (10% vs. 2%, p = .03), while 2‐year mortality rates were similar (34% vs. 20%, p = .09). Multivariable analysis revealed higher AM grades and post‐procedural MR as predictors of in‐hospital mortality and lack of procedural success for 2‐year mortality.

Conclusions

Among patients with LVEF ≤35% and severe FMR undergoing TEER, AM was associated with in‐hospital mortality but did not impact long‐term outcomes. Proportionate MR increased the risk of AM, while pretreatment with levosimendan and higher furosemide doses was protective.

Subjects

MeSH terms (MEDLINE)

Mitral Valve InsufficiencyVentricular Dysfunction, LeftHumansMaleFemaleAgedPropensity ScoreHospital MortalityCase-Control StudiesStroke VolumeMiddle AgedCardiotonic AgentsSimendanCardiac CatheterizationFurosemideTreatment Outcome

Author keywords

HFrEFTEERafterload mismatchlevosimendanmitral regurgitation

Substances

Cardiotonic AgentsSimendanFurosemide

Authors and institutions

  • Division of Cardiology, Cardiovascular and Thoracic Department, 'Città Della Salute e Della Scienza' Hospital, Torino, Italy.
  • Division of Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Padova, Italy.
  • Interventional Cardiology Unit, GVM Care & Research Maria Cecilia Hospital, Cotignola, Italy.
  • Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy.

ORCID profiles: Filippo Angelini, Alessandro Mandurino Mirizzi

Cite

APA

Angelini, F., Pidello, S., Frea, S., Bocchino, P. P., Mandurino Mirizzi, A., Pavon, A. G., Montonati, C., Giannini, F., Giovannini, D., Mangieri, A., Reimers, B., Boretto, P., Gallone, G., Dusi, V., Cavallone, E., De Filippo, O., Crimi, G., Tarantini, G., Raineri, C., …, & De Ferrari, G. M. (2025). Afterload mismatch after transcatheter edge‐to‐edge repair in functional mitral regurgitation: A propensity‐score matched analysis. European Journal of Clinical Investigation, 55(8). https://doi.org/10.1111/eci.70040

Vancouver

Angelini F, Pidello S, Frea S, Bocchino PP, Mandurino Mirizzi A, Pavon AG, et al. Afterload mismatch after transcatheter edge‐to‐edge repair in functional mitral regurgitation: A propensity‐score matched analysis. European Journal of Clinical Investigation. 2025;55(8). doi:10.1111/eci.70040

BibTeX
@article{Angelini2025,
  author = {Angelini, Filippo and Pidello, Stefano and Frea, Simone and Bocchino, Pier Paolo and Mandurino Mirizzi, Alessandro and Pavon, Anna Giulia and Montonati, Carolina and Giannini, Francesco and Giovannini, Davide and Mangieri, Antonio and Reimers, Bernhard and Boretto, Paolo and Gallone, Guglielmo and Dusi, Veronica and Cavallone, Elena and De Filippo, Ovidio and Crimi, Gabriele and Tarantini, Giuseppe and Raineri, Claudia and Pedrazzini, Giovanni and D'Ascenzo, Fabrizio and Biasco, Luigi and De Ferrari, Gaetano Maria},
  title = {Afterload mismatch after transcatheter edge‐to‐edge repair in functional mitral regurgitation: A propensity‐score matched analysis},
  journal = {European Journal of Clinical Investigation},
  year = {2025},
  volume = {55},
  number = {8},
  doi = {10.1111/eci.70040}
}
Start for free →